About Viz.ai, Inc. Viz.ai is the pioneer in the use of AI algorithms and machine learning to increase the speed of diagnosis and care across 1,700+ hospitals and health systems in the U.S. and Europe.

Viz.ai's recent partnership with Sanofi and Regeneron Pharmaceuticals (NasdaqGS:REGN) brings AI technology to aid in the management of COPD patients, enhancing the healthcare process. Throughout ...

Regeneron’s Reid expresses a contrarian view however, concluding from his vantage point, “I am an AI pessimist. AI/ML is high hanging fruit from where I sit.

--Regeneron Pharmaceuticals, Inc. today announced a five-year, $5 million strategic investment to bolster Nashville, Tennessee’ s science, technology, engineering and mathematics ecosystem ...

Commitment builds on Regeneron’s longstanding efforts to develop the STEM talent pipeline as lead sponsor of the premier high school competitions, the Regeneron Science Talent Search (STS) and ...

Today's health tech news covers Regeneron's new health tech deals, fundraisers from Cohere, Sprinter, Akido, and Commure's legal trouble. Skip to Main Content Manage alerts for this article ...

Using artificial intelligence and archival news articles, a teenager in Northern Virginia created a program to measure media biases – and in researching older news articles, she found that Black ...

Viz.ai is to enter a multi-year collaboration with Sanofi and Regeneron aimed at deploying and assessing an AI-powered workflow solution for improving the management of chronic obstructive ...